Literature DB >> 27396249

Risk of bias and methodological appraisal practices in systematic reviews published in anaesthetic journals: a meta-epidemiological study.

B N Detweiler1, L E Kollmorgen1, B A Umberham1, R J Hedin1, B M Vassar1.   

Abstract

The validity of primary study results included in systematic reviews plays an important role in drawing conclusions about intervention effectiveness and carries implications for clinical decision-making. We evaluated the prevalence of methodological quality and risk of bias assessments in systematic reviews published in the five highest-ranked anaesthesia journals since 2007. The initial PubMed search yielded 315 citations, and our final sample after screening consisted of 207 systematic reviews. One hundred and seventy-four reviews conducted methodological quality/risk of bias analyses. The Jadad scale was most frequently used. Forty-four of the 83 reviews that included high risk of bias studies re-analysed their data omitting these trials: 20 showed differences in pooled effect estimates. Reviews containing a greater number of primary studies evaluated quality less frequently than smaller reviews. Overall, the majority of reviews evaluated bias; however, many applied questionable methods. Given the potential effects of bias on summary outcomes, greater attention is warranted.
© 2016 The Association of Anaesthetists of Great Britain and Ireland.

Keywords:  cochrane; meta-analysis; research quality; risk of bias; systematic review

Mesh:

Year:  2016        PMID: 27396249     DOI: 10.1111/anae.13520

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  7 in total

1.  Why most published meta-analysis findings are false.

Authors:  B Doleman; J P Williams; J Lund
Journal:  Tech Coloproctol       Date:  2019-06-25       Impact factor: 3.781

2.  Methodological quality of systematic reviews referenced in clinical practice guidelines for the treatment of opioid use disorder.

Authors:  Andrew Ross; Justin Rankin; Jason Beaman; Kelly Murray; Philip Sinnett; Ross Riddle; Jordan Haskins; Matt Vassar
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

3.  Methodological tools and sensitivity analysis for assessing quality or risk of bias used in systematic reviews published in the high-impact anesthesiology journals.

Authors:  Marija Franka Marušić; Mahir Fidahić; Cristina Mihaela Cepeha; Loredana Gabriela Farcaș; Alexandra Tseke; Livia Puljak
Journal:  BMC Med Res Methodol       Date:  2020-05-18       Impact factor: 4.615

4.  Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis.

Authors:  Stefan Schraag; Lorenzo Pradelli; Abdul Jabbar Omar Alsaleh; Marco Bellone; Gianni Ghetti; Tje Lin Chung; Martin Westphal; Sebastian Rehberg
Journal:  BMC Anesthesiol       Date:  2018-11-08       Impact factor: 2.217

Review 5.  Patient-Related Risk Factors for Unplanned 30-Day Hospital Readmission Following Primary and Revision Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.

Authors:  Daniel Gould; Michelle M Dowsey; Tim Spelman; Olivia Jo; Wassif Kabir; Jason Trieu; James Bailey; Samantha Bunzli; Peter Choong
Journal:  J Clin Med       Date:  2021-01-02       Impact factor: 4.241

6.  Are systematic reviews addressing nutrition for cancer prevention trustworthy? A systematic survey of quality and risk of bias.

Authors:  Joanna F Zajac; Dawid Storman; Mateusz J Swierz; Magdalena Koperny; Paulina Weglarz; Wojciech Staskiewicz; Magdalena Gorecka; Anna Skuza; Adam Wach; Klaudia Kaluzinska; Justyna Bochenek-Cibor; Bradley C Johnston; Malgorzata M Bala
Journal:  Nutr Rev       Date:  2022-05-09       Impact factor: 6.846

7.  Comparative effectiveness of pharmacological interventions to prevent postoperative delirium: a network meta-analysis.

Authors:  Sun-Kyung Park; Taeyoon Lim; Hyeyeon Cho; Hyun-Kyu Yoon; Ho-Jin Lee; Ji-Hyun Lee; Seokha Yoo; Jin-Tae Kim; Won Ho Kim
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.